ShareProphets readership increases every week - we can tell because we're a registration site and if you unsubscribe, you are kicked off the site. We don't have a dead subscription list like other, lesser, sites.
I have been greatly distracted not least dealing with this utterly brain dead and vile Cloudtag (CTAG) shareholder who has been spamming me with the most ghastly abuse all day. I look at the Bob Diamond bid for Panmure Gordon (PMR) and what it means for the wider broking/corporate advisory sector. I then turn to Premaitha (NIPT) and the wider issue of the pointlessness of commissioned research. I touch on Management Resource Solutions (MRS) in light of the news earlier HERE but now the way it is really trying to screw shareholders with a 5p placing. There is comment on Jubilee Platinum (JLP). Then it is back to two old favourites: Advanced Oncotherapy (AVO) and Milestone (MSG). Woof Woof.
There are not many who would deny that it has been a decent price ride for Barclays (BARC) shares since last summer – ironically since we were treated to the Libor scandal that people already seem to have forgotten about.